🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10153+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 10153 recruiting trials

Phase 3RecruitingNCT06930625

A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs

🏥 Debiopharm International SA📍 71 sites📅 Started Nov 2025View details ↗
Phase 1RecruitingNCT07176650

Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma

🏥 Shanghai Henlius Biotech📍 51 sites📅 Started Nov 2025View details ↗
Phase 2RecruitingNCT07142291

PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS

🏥 PhenoNet, Inc.📍 12 sites📅 Started Nov 2025View details ↗
RecruitingNCT07018076

Candidate Clinical Correlate of Prognostic Outcome for TB Study

👨‍⚕️ Adithya Cattamanchi, MD, University of California San Francisco; University of California Irvine📍 3 sites📅 Started Nov 2025View details ↗
Phase 3Enrolling by InvitationNCT06736691

Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections

👨‍⚕️ Jennifer Keiser, Professor, Swiss Tropical & Public Health Institute📍 1 site📅 Started Nov 2025View details ↗
Phase 1, PHASE2RecruitingNCT07414212

Evaluation of the Combined Therapy of EH-301 and N-acetylcysteine Together With Riluzole in Amyotrophic Lateral Sclerosis (ALS)

🏥 Biogipuzkoa Health Research Institute📍 1 site📅 Started Nov 2025View details ↗
Phase 1, PHASE2RecruitingNCT07223047

A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies

👨‍⚕️ Bristol-Myers Squibb, Bristol-Myers Squibb📍 8 sites📅 Started Nov 2025View details ↗
NARecruitingNCT07334964

Ultrasound-Guided Carpal Tunnel Infiltration: Comparison Between the Manual Method and a Robot-Assisted Method

👨‍⚕️ Camille LANGBOUR, Dr, CHU Orléans📍 1 site📅 Started Nov 2025View details ↗
Phase 1RecruitingNCT07226219

Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease

👨‍⚕️ Andrew Heitzer, PhD, St. Jude Children's Research Hospital📍 1 site📅 Started Nov 2025View details ↗
NARecruitingNCT07188532

Biologically-Adapted, Dose-Escalated Radiotherapy for the Treatment of Ewing Sarcoma, BEAR Trial

👨‍⚕️ Roman O. Kowalchuk, MD, Mayo Clinic in Rochester📍 1 site📅 Started Nov 2025View details ↗
RecruitingNCT07356882

European Project for ctDNA Detection as a Biomarker for Non-invasive Therapy Monitoring in Paediatric Classical Hodgkin Lymphoma

👨‍⚕️ Mathieu SIMONIN, MD, Assistance Publique - Hôpitaux de Paris📍 1 site📅 Started Nov 2025View details ↗
RecruitingNCT07422844

Dynamic Network Response to TMS Treatment

🏥 Goethe University📍 1 site📅 Started Nov 2025View details ↗
Phase 2RecruitingNCT07123090

A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma

👨‍⚕️ Stephanie Berg, DO, Dana-Farber Cancer Institute📍 2 sites📅 Started Nov 2025View details ↗
Phase 1RecruitingNCT07236762

An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

🏥 China Immunotech (Beijing) Biotechnology Co., Ltd.📍 1 site📅 Started Nov 2025View details ↗
Phase 1RecruitingNCT06827470

Establishing a Controlled Human Infection Model of Pertactin-deficient Bordetella Pertussis

🏥 Dalhousie University📍 1 site📅 Started Nov 2025View details ↗
Phase 1, PHASE2RecruitingNCT07052695

Mosunetuzumab for CLL MRD Clearance

👨‍⚕️ Inhye Ahn, MD, Dana-Farber Cancer Institute📍 2 sites📅 Started Nov 2025View details ↗
RecruitingNCT07250906

Oral Health Related Quality of Life of Children With Amelogenesis Imperfecta

🏥 Istanbul University📍 1 site📅 Started Nov 2025View details ↗
Phase 1RecruitingNCT07261631

Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors

🏥 Novartis Pharmaceuticals📍 5 sites📅 Started Nov 2025View details ↗
Phase 2RecruitingNCT07209462

Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)

🏥 Mirum Pharmaceuticals, Inc.📍 15 sites📅 Started Nov 2025View details ↗
RecruitingNCT07090460

Pulmonary Overdistension Assessment With Electrical Impedance Tomography in Patients With Acute Respiratory Distress Syndrom in Prone Position.

🏥 Centre Hospitalier de la côte Basque📍 1 site📅 Started Nov 2025View details ↗
← PreviousPage 42 of 508Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →